Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics - PubMed (original) (raw)
Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics
T Steer et al. Nutr Res Rev. 2000 Dec.
Abstract
One of the most topical areas of human nutrition is the role of the gut in health and disease. Specifically, this involves interactions between the resident microbiota and dietary ingredients that support their activities. Currently, it is accepted that the gut microflora contains pathogenic, benign and beneficial components. Some microbially induced disease states such as acute gastroenteritis and pseudomembranous colitis have a defined aetiological agent(s). Speculation on the role of microbiota components in disorders such as irritable bowel syndrome, bowel cancer, neonatal necrotising enterocolitis and ulcerative colitis are less well defined, but many studies are convincing. It is evident that the gut microflora composition can be altered through diet. Because of their perceived health-promoting status, bifidobacteria and lactobacilli are the commonest targets. Probiotics involve the use of live micro-organisms in food; prebiotics are carbohydrates selectively metabolized by desirable moieties of the indigenous flora; synbiotics combine the two approaches. Dietary intervention of the human gut microbiota is feasible and has been proven as efficacious in volunteer trials. The health bonuses of such approaches offer the potential to manage many gut disorders prophylactically. However, it is imperative that the best methodologies available are applied to this area of nutritional sciences. This will undoubtedly involve a genomic application to the research and is already under way through molecular tracking of microbiota changes to diet in controlled human trials.
Similar articles
- Prebiotic effects: metabolic and health benefits.
Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco MJ, Léotoing L, Wittrant Y, Delzenne NM, Cani PD, Neyrinck AM, Meheust A. Roberfroid M, et al. Br J Nutr. 2010 Aug;104 Suppl 2:S1-63. doi: 10.1017/S0007114510003363. Br J Nutr. 2010. PMID: 20920376 Review. - Probiotics and prebiotics in infant nutrition.
Parracho H, McCartney AL, Gibson GR. Parracho H, et al. Proc Nutr Soc. 2007 Aug;66(3):405-11. doi: 10.1017/S0029665107005678. Proc Nutr Soc. 2007. PMID: 17637093 Review. - Prebiotics as gut microflora management tools.
Gibson GR. Gibson GR. J Clin Gastroenterol. 2008 Jul;42 Suppl 2:S75-9. doi: 10.1097/MCG.0b013e31815ed097. J Clin Gastroenterol. 2008. PMID: 18542038 - Microbial-gut interactions in health and disease. Prebiotics.
Manning TS, Gibson GR. Manning TS, et al. Best Pract Res Clin Gastroenterol. 2004 Apr;18(2):287-98. doi: 10.1016/j.bpg.2003.10.008. Best Pract Res Clin Gastroenterol. 2004. PMID: 15123070 Review. - Probiotics as modulators of the gut flora.
Fooks LJ, Gibson GR. Fooks LJ, et al. Br J Nutr. 2002 Sep;88 Suppl 1:S39-49. doi: 10.1079/BJN2002628. Br J Nutr. 2002. PMID: 12215180 Review.
Cited by
- Co-Supplementation of Baobab Fiber and Arabic Gum Synergistically Modulates the In Vitro Human Gut Microbiome Revealing Complementary and Promising Prebiotic Properties.
Duysburgh C, Govaert M, Guillemet D, Marzorati M. Duysburgh C, et al. Nutrients. 2024 May 22;16(11):1570. doi: 10.3390/nu16111570. Nutrients. 2024. PMID: 38892504 Free PMC article. - The effect of different prebiotics on intestinal probiotics in newly diagnosed diabetic patients.
Zhang Y, Yang L, Wu Y, He H, Zeng Y, An Z, Jia W. Zhang Y, et al. Food Sci Nutr. 2023 Sep 24;11(12):7921-7929. doi: 10.1002/fsn3.3709. eCollection 2023 Dec. Food Sci Nutr. 2023. PMID: 38107105 Free PMC article. - Dietary Supplementation of Microbial Dextran and Inulin Exerts Hypocholesterolemic Effects and Modulates Gut Microbiota in BALB/c Mice Models.
Jawad I, Bin Tawseen H, Irfan M, Ahmad W, Hassan M, Sattar F, Awan FR, Khaliq S, Akhtar N, Akhtar K, Anwar MA, Munawar N. Jawad I, et al. Int J Mol Sci. 2023 Mar 10;24(6):5314. doi: 10.3390/ijms24065314. Int J Mol Sci. 2023. PMID: 36982388 Free PMC article. - Isomaltooligosaccharides Sustain the Growth of Prevotella Both In Vitro and in Animal Models.
Chen J, Li Z, Wang X, Fan B, Deng F, D Yu H, Ze X, Zhu L, Yin Y, Chen Y, Zhao J, Yang Y, Wang X. Chen J, et al. Microbiol Spectr. 2022 Dec 21;10(6):e0262121. doi: 10.1128/spectrum.02621-21. Epub 2022 Nov 15. Microbiol Spectr. 2022. PMID: 36377936 Free PMC article. - Lactobacillus reuteri MJM60668 Prevent Progression of Non-Alcoholic Fatty Liver Disease through Anti-Adipogenesis and Anti-inflammatory Pathway.
Werlinger P, Nguyen HT, Gu M, Cho JH, Cheng J, Suh JW. Werlinger P, et al. Microorganisms. 2022 Nov 7;10(11):2203. doi: 10.3390/microorganisms10112203. Microorganisms. 2022. PMID: 36363795 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources